Darius Moshfeghi, MD
Retina Specialist · Palo Alto, CANPI 1386702819
Payments from drug & device makers
Across 142 payments — averaging $10,813 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$721K
- Ocular Therapeutix, Inc.$566K
- Bayer$87K
- Regeneron$63K
- Novartis Pharma AG$44K
- Apellis Pharmaceuticals, Inc.$42K
- plus $13K from 10 others
Across 26 payments — averaging $5773.52 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Novartis Pharma AG$144K
- Regeneron$5K
- F. Hoffmann-la Roche AG$281
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 38 | $721,034 |
| Ocular Therapeutix, Inc. | 53 | $565,802 |
| Bayer | 9 | $86,814 |
| Regeneron | 13 | $62,554 |
| Novartis Pharma AG | 2 | $44,269 |
| Apellis Pharmaceuticals, Inc. | 10 | $42,120 |
| Boehringer Ingelheim International GmbH | 2 | $4,250 |
| Alcon | 7 | $3,764 |
| Akebia Therapeutics Inc | 1 | $3,000 |
| Genentech, Inc. | 1 | $1,515 |
| Topcon Healthcare, Inc. | 1 | $84 |
| Eyepoint US, Inc. | 1 | $81 |
| Novartis | 1 | $77 |
| AbbVie | 1 | $66 |
| Astellas Pharma US Inc | 1 | $42 |
| Carl Zeiss Meditec AG | 1 | $19 |
How this compares
$1,535,490 in reported general payments places this provider in the 90th percentile of 187 retina specialist providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other retina specialist in Palo Alto
- Dante PieramiciSanta Barbara$15.1M
- Margaret ChangSacramento$13.2M
- Hani Salehi-HadHuntington Beach$12.2M
- Payam AminiPasadena$9.9M
- Joel PearlmanSacramento$8.3M
- Dilsher DhootSanta Barbara$8.2M
- Ashkan PirouzFullerton$6.9M
- Roger GoldbergWalnut Creek$5M
- Sean AdreanFullerton$2.9M
- Nathan SteinleSanta Barbara$2.6M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.